Ignite Creation Date:
2025-12-26 @ 12:16 PM
Ignite Modification Date:
2026-03-03 @ 1:14 PM
Study NCT ID:
NCT04934800
Status:
COMPLETED
Last Update Posted:
2025-06-24
First Post:
2021-06-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)
Sponsor:
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Organization: